In a crowded ward in Malawi, a man died — his life lost in part because lifesaving HIV medications and diagnostics, funded by USAID, were suddenly unavailable. The day before, I had watched him, in his forties, unconscious, as his uncle struggled to hold him as he tipped water into his mouth.
Sweat beaded up over the right side of his face and body, sparing the left — a puzzling sign. The next day, we learned he had died from tuberculosis meningitis.
I know, because I am an American resident doctor who worked alongside the local doctors. The USAID cuts coincided with the beginning of my two-month rotation at Kamuzu Central Hospital (KCH) in Lilongwe, the capital of Malawi.
A third of patients died
In late January, the Trump administration suspended most USAID operations. Overnight, treatments for many diseases life became inaccessible, including saving HIV medications. HIV-related care in places like Malawi fell into chaos.
Since 2003, the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), administered by USAID, has invested $110 billion and saved 26 million lives— roughly every person living in NYC, LA, Chicago, and Houston combined — for less than 0.2% of the federal budget.
In Malawi, a third of our patients died. The future of one young man, now blind from an infection behind his eye, was crippled by a broken CT machine. Faulty laboratory equipment paralyzed straightforward management. Medical records amounted to handwritten notes in booklets carried by patients. Despite these barriers, the medical staff educates and provides the best treatment they can.
Lighthouse Trust, a grantee of the CDC as part of PEPFAR, plays a major role in HIV care in country where 8% of the population is HIV positive. At KCH, Lighthouse provides HIV primary care to over 12,000 patients.
Lighthouse runs expensive testing key to HIV management, including monitoring counts of the white bloods cells that help qualify immunocompromise and each patient’s burden of disease. They dispense anti-retroviral treatment. They perform specialized testing and ultrasounds for tuberculosis.
In the weeks following the USAID changes, Lighthouse was thrown into disarray. Services were cut off, staff sent home, and afternoon clinics were covered by overworked residents. Some services have since returned under Secretary of State Marco Rubio’s temporary waiver for lifesaving medicines and medical services, but uncertainty remains.
Life expectancy increased
Due in large part to U.S.-funded efforts, HIV in Malawi is about half as common as it was twenty years ago. Now, 98% of patients diagnosed with HIV are on treatment. Improvements in HIV care help explain Malawi’s vastly improved life expectancy, which has increased by 21 years since 2000. However, with USAID’s future uncertain, a dangerous vacuum is emerging.
Critics argue that U.S. taxpayers should prioritize domestic needs over international aid. They question whether it is fair for the U.S. to shoulder the burden of global health care, especially in countries where local governments might become reliant on external funding. Some believe that international aid fosters dependence instead of encouraging self-sufficiency.
While these concerns merit discussion, the facts on the ground tell a different story. Malawi’s improved life expectancy and reduced HIV rates demonstrate that external investment yields lasting public health gains. Moreover, in a world where infectious diseases cross borders quickly, cutting support isn’t just an ethical failure — it’s a public health risk for everyone.
No one knows how Malawi’s USAID vacuum will be filled. In a country where international sources fund over 50% of the healthcare budget, money may be shifted from other programs, such as initiatives funding cancer treatment.
Though I consider global health a worthwhile pursuit, the gaping hole created by USAID’s functional closure reminds me of its limitations. Outside funding can disappear. Local health systems can become overly dependent on outside support.
Where do we draw the line between what outsiders establish as the needs of the destitute versus the needs identified by the local population? Still, one cannot overlook the lives and life years gained for an ounce of the U.S.’s GDP.
The grief amplifies
Asked about the uncertainty and challenges of practicing medicine here, a supervising doctor remarked, “many times our goal is to do no harm.” As a doctor, this intention is core to my practice. President Trump’s withdrawal from USAID harms both the people America serves and damages our relationship to the world.
On my last weekend in Malawi, we passed through a village just outside Lilongwe. Beneath the shade of Moringa trees, hundreds formed quiet circles, gathered for a funeral. When someone dies, the whole village grieves. I wondered if our patient’s village gathered like this one and how this grief would amplify across this country and the next as the United States turns inward, and the life-giving aid we provide falters.
One village’s grief is a stark reminder: when the U.S. retreats from global health leadership, the cost is measured in human lives. Congress must ensure USAID’s lifesaving programs continue — because no one should die for lack of medicine we have the power to provide.
Paul C. Holden is a rising third year resident physician in internal medicine at the University of Pittsburgh Medical Center. He lives in Bloomfield.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.